CONSULTING SERVICES AGREEMENTConsulting Services Agreement • November 19th, 2013 • Immune Pharmaceuticals Inc • Pharmaceutical preparations
THIS CONSULTING SERVICES AGREEMENT (this "Agreement"), is made and entered into as of August 10, 2013 (the "Effective Date"), by and between Immune Pharmaceuticals Ltd., a company registered under the laws of the State of Israel (together with any of its affiliates and subsidiaries, the "Company") and Jean Elie Kadouche ("Consultant"). Company and Consultant may be referred to herein individually as a "Party" and collectively as the "Parties".
OPTION AGREEMENTOption Agreement • November 19th, 2013 • Immune Pharmaceuticals Inc • Pharmaceutical preparations
THIS OPTION AGREEMENT (this "Agreement") is made and entered into as of August 10 , 2013 by and between Immune Pharmaceuticals Ltd., a company registered under the laws of the State of Israel (the "Company") and Melini Capital Corp., a company registered under the laws of Panana (the "Grantee") (the Company and the Grantee shall sometimes be referred to, each as a "Party" and collectively, as the "Parties").
SERVICES AGREEMENTServices Agreement • November 19th, 2013 • Immune Pharmaceuticals Inc • Pharmaceutical preparations
THIS SERVICES AGREEMENT (this “Agreement”), is made and entered into as of August 6, 2013 (the “Effective Date”), by and between Immune Pharmaceuticals Ltd., a company registered under the laws of the State of Israel, with registration number 514471283 (the “Company”) and Melini Capital Corp., a company registered under the laws of Panana (“Consultant”). Company and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties”.
